The global protein chip market size is expected to reach USD 1370.49 Million at a steady revenue CAGR of 7.5% in 2030, according to latest analysis by Emergen Research. Protein chip market revenue growth can be attributed to factors such as increasing prevalence of cancer globally. Cancer, as one of the most taxing diseases, necessitates functional research in order to comprehend its complicated and heterogeneous nature. Microarray is a sophisticated technology that allows for diagnosis of thousands of genes or RNA products at the same time on a single platform. Proteome chip technology is a unique high-throughput approach for probing a large number of proteins, and it has proven to be a useful tool in cancer research and detection. A recent trend observed in the market is products applications for enzyme substrate, DNA protein, and different types of protein-protein interactions. Within a single experiment, microarray technology enables for the simultaneous diagnosis of various factors. Microspots of capture molecules are immobilized on a solid platform in rows and columns, and exposed to samples containing the appropriate binding molecules. To detect complex formation within each microspot, readout methods based on fluorescence, chemiluminescence, mass spectrometry, radioactivity, or electrochemistry can be utilized. Capability of the technology is shown by array-based gene expression analysis, which uses downsized and parallelized binding experiments. Arrays of immobilized DNA probes are exposed to complementary targets in these devices, and the degree of hybridization is evaluated. https://www.emergenresearch.com/industry-report/protein-chip-market